v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 62,620 $ 74,317
Short-term investments 264,565 184,792
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 12,053 13,689
Total current assets 339,432 272,992
Property and equipment, net 51,954 54,176
Operating lease assets 12,069 14,007
Restricted cash - long-term 1,200 1,200
Other assets 877 567
Total assets 405,532 342,942
Current liabilities:    
Accounts payable 5,190 7,963
Accrued compensation 16,710 14,706
Accrued research and development expenses 8,883 8,341
Other current liabilities 5,272 5,733
Total current liabilities 36,055 36,743
Operating lease liabilities - long-term 13,129 14,136
Other long-term liabilities 2,413 1,282
Total liabilities 51,597 52,161
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of September 30, 2020 and December 31, 2019; 77,220 and 56,806 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 8 6
Additional paid-in capital 1,396,674 1,108,516
Accumulated other comprehensive income 527 220
Accumulated deficit (1,043,274) (817,961)
Total stockholders’ equity 353,935 290,781
Total liabilities and stockholders’ equity $ 405,532 $ 342,942

Source